| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | 6.8% | Deutsche Bank | → $217 | Initiates Coverage On | → Hold |
| 02/13/2023 | 16.15% | Bernstein | $247 → $236 | Maintains | Market Perform |
| 02/10/2023 | 13.19% | Credit Suisse | $244 → $230 | Maintains | Neutral |
| 01/12/2023 | 20.08% | Credit Suisse | $259 → $244 | Maintains | Neutral |
| 12/15/2022 | -6.49% | Goldman Sachs | $171 → $190 | Maintains | Sell |
| 11/15/2022 | 23.04% | JP Morgan | $258 → $250 | Maintains | Neutral |
| 11/11/2022 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 11/04/2022 | 27.47% | Credit Suisse | $245 → $259 | Maintains | Neutral |
| 10/12/2022 | 20.58% | Credit Suisse | → $245 | Initiates Coverage On | → Neutral |
| 10/11/2022 | 55.03% | Wolfe Research | → $315 | Initiates Coverage On | → Outperform |
| 04/14/2022 | 32.88% | Cowen & Co. | $200 → $270 | Upgrades | Market Perform → Outperform |
| 02/14/2022 | 3.35% | JP Morgan | $220 → $210 | Maintains | Neutral |
| 12/15/2021 | 10.73% | Wolfe Research | → $225 | Initiates Coverage On | → Outperform |
| 11/11/2021 | 5.81% | B of A Securities | $240 → $215 | Downgrades | Buy → Neutral |
| 11/08/2021 | 4.34% | Barclays | $230 → $212 | Maintains | Equal-Weight |
| 01/06/2021 | -12.89% | Vertical Research | → $177 | Downgrades | Buy → Hold |
| 11/09/2020 | -13.38% | Bernstein | $202 → $176 | Maintains | Market Perform |
| 10/02/2020 | -13.87% | JP Morgan | $205 → $175 | Maintains | Neutral |
| 10/01/2020 | -21.26% | Barclays | $190 → $160 | Maintains | Equal-Weight |
| 06/11/2020 | 32.88% | UBS | $290 → $270 | Maintains | Buy |
| 05/22/2020 | -6.49% | Stifel | $230 → $190 | Upgrades | Sell → Hold |
| 05/21/2020 | 4.83% | RBC Capital | → $213 | Initiates Coverage On | → Outperform |
| 05/19/2020 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 04/28/2020 | 0.4% | Credit Suisse | $284 → $204 | Downgrades | Outperform → Neutral |
| 02/27/2020 | 19.1% | Buckingham Research | $300 → $242 | Downgrades | Buy → Neutral |
| 02/19/2020 | 42.72% | UBS | $300 → $290 | Maintains | Buy |
| 02/18/2020 | — | Alembic Global | Downgrades | Overweight → Neutral | |
| 02/14/2020 | 47.65% | UBS | $310 → $300 | Maintains | Buy |
| 01/30/2020 | 45.68% | Credit Suisse | $298 → $296 | Maintains | Outperform |
| 01/22/2020 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 01/15/2020 | 57.49% | UBS | $300 → $320 | Maintains | Buy |
| 11/08/2019 | 47.65% | UBS | $275 → $300 | Maintains | Buy |
| 08/08/2019 | 30.42% | Buckingham Research | $295 → $265 | Maintains | Buy |
| 08/06/2019 | 35.34% | B of A Securities | $305 → $275 | Reiterates | → Buy |
| 01/23/2019 | 5.81% | Barclays | $245 → $215 | Downgrades | Overweight → Underweight |
| 01/14/2019 | 18.12% | Citigroup | $260 → $240 | Maintains | Buy |
| 12/04/2018 | 20.58% | Barclays | $280 → $245 | Maintains | Overweight |
| 10/11/2018 | 2.37% | Goldman Sachs | → $208 | Downgrades | Neutral → Sell |
What is the target price for Huntington Ingalls Indus (HII)?
There is no price target for Huntington Ingalls Indus
What is the most recent analyst rating for Huntington Ingalls Indus (HII)?
There is no analyst for Huntington Ingalls Indus
When is the next analyst rating going to be posted or updated for Huntington Ingalls Indus (HII)?
There is no next analyst rating for Huntington Ingalls Indus
Is the Analyst Rating Huntington Ingalls Indus (HII) correct?
There is no next analyst rating for Huntington Ingalls Indus